MINERALYS THERAPEUTICS INC (MLYS)
US6031701013 - Common Stock
ChartMill assigns a Buy % Consensus number of 86% to MLYS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 33.66. This target is 187.94% above the current price.
MLYS was analyzed by 14 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about MLYS.
In the previous month the buy percentage consensus was at a similar level.
MLYS was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-10 | HC Wainwright & Co. | Initiate | Buy |
| 2024-04-02 | Goldman Sachs | Initiate | Buy |
| 2023-08-08 | Credit Suisse | Maintains | Outperform -> Outperform |
| 2023-05-16 | Credit Suisse | Reiterate | Outperform -> Outperform |
| 2023-03-16 | Credit Suisse | Maintains | Outperform |
| 2023-03-07 | Guggenheim | Initiate | Buy |
| 2023-03-07 | Stifel | Initiate | Buy |
| 2023-03-07 | Wells Fargo | Initiate | Overweight |
| 2023-03-07 | Evercore ISI Group | Initiate | Outperform |
| 2023-03-07 | Credit Suisse | Initiate | Outperform |
| 2023-03-07 | B of A Securities | Initiate | Buy |